Expiration date: 01/2026

Liarsin is a homeopathic drug for the correction of metabolic processes, prevention and treatment of inflammatory diseases of the gastrointestinal tract in animals. Dosage form: solution for injection. In appearance, the drug is a colorless transparent liquid.

Structure

Liarsin as active substances contains matrix tincture of vegetable origin and mineral components (in 1000 ml): Lycopodium clavatum Ø= D1 1 nl, Acidum arsenicosum Ø= D2 0.01 nl, Phosphorus D26 3 ml and excipients: sodium chloride - 9 g, water for injection up to 1000 ml.

PHARMACOLOGICAL PROPERTIES

Liarsin refers to combined homeopathic medicines. It has a regulating effect on metabolic processes, restores impaired functions of the gastrointestinal tract, stimulates the immune system associated with the gastrointestinal tract (mucose-associated lymphoid tissues of the intestine).

According to the degree of effect on the body of the drug, Liarsin belongs to low-hazard substances (hazard class 4 according to GOST 12.1.007-76), does not have a locally irritating and sensitizing effect.

DOSAGE AND APPLICATION

Liarsin is prescribed to cattle, horses, pigs, sheep, goats, minks, dogs and cats of all age groups for the correction of metabolic processes, as well as for the treatment and prevention of diseases of the gastrointestinal tract (gastritis, gastroenteritis).

Liarsin is administered to animals intramuscularly or subcutaneously.

For correction of metabolic processes and prevention of gastrointestinal diseases 2-3 times, with an interval of 7-10 days between injections; for therapeutic purposes 4-6 times, with an interval between injections of 24 - 48 hours.

A single dose of the drug per animal is: horses - 10.0-15.0 ml; cattle - 5.0-10.0 ml; pigs - 2.5-5.0 ml; goats, sheep - 2.0-2.5 ml; foals, calves, piglets - 2.0-2.5 ml; dogs of large and medium breeds - 2.0-4.0 ml dogs of small breeds, cats, puppies, minks - 0.5-2.0 ml.

SPECIAL INSTRUCTIONS

Symptoms of overdose in animals have not been established.

The peculiarities of the drug's action during its first use and cancellation were not revealed.

Skipping the next dose of the drug should be avoided, as this may lead to a decrease in effectiveness. If one dose is missed, the use of the drug should be resumed as soon as possible in the same dose and according to the same scheme. Further, the interval until the next administration of the drug does not change.

With increased individual sensitivity and allergic reactions, the use of the drug is discontinued and antihistamines, beta-adrenomimetics, corticosteroids or other means of symptomatic therapy are prescribed.

The use of Liarsin does not exclude the use of other drugs for etiotropic, pathogenetic and symptomatic therapy.

Animal products during and after the application of Liarsin® can be used without restrictions.

Contraindications

Contraindication to the use of Liarsin is individual intolerance to the components of the drug.

SIDE EFFECTS

When using Liarsin in accordance with this instruction, side effects and complications are usually not noted.

SHELF LIFE AND STORAGE

The drug is stored in the manufacturer's closed packaging, separately from food and feed, in a dry place protected from direct sunlight, at a temperature from 0 ° C to 25 ° C.

The shelf life of the drug, subject to storage conditions in a closed package, is 3 years from the date of production.